Brief: Galectin Therapeutics Inc Reports Quarterly Loss Per Share $0.19
15/05/2023 12:59
May 15 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS INC QUARTERLY LOSS PER SHARE $0.19
* GALECTIN THERAPEUTICS - WILL REQUIRE MORE CASH TO FUND
OPERATIONS AFTER DEC 31, 2024, BELIEVES WILL BE ABLE TO OBTAIN
ADDITIONAL FINANCING AS NEEDED
Source text for Eikon: ID:
Further company coverage: GALT.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study